DSM has signed contracts with North China Pharmaceutical Group Co. regarding the establishment of three joint ventures in the areas of nutritional products and anti-infectives. DSM will buy a 10% stake in NCPC. The two firms will form a vitamin C joint venture in which DSM holds a 30% stake and two bulk antibiotics joint ventures, each 51% owned by DSM. In all, DSM will invest about $110 million. DSM has long sought a partner for its anti-infectives business. It signed a preliminary agreement with NCPC in 2004.